BSE filing, NSE: LAURUSLABS. Summary written from the filing by ALFA Finder's alert engine.
Laurus Labs Ltd: key numbers
- Share price
- ₹2,170.00
- Market cap
- ₹1,17,248 Cr
- Revenue (annual)
- ₹6,813 Cr
- Net profit (annual)
- ₹888.8 Cr
- P/E (TTM)
- 107.2×Sector 46.1×
- Promoter holding
- 27.47%+0.00% QoQ
- FII holding
- 30.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laurus Labs Ltd
All →Laurus Labs Results Update
Laurus Labs reported H1 FY27 revenue of ₹4,233 Cr and EBITDA of ₹1,406 Cr. The company acquired Galenvs Sciences and SI&C Resins to expand CDMO capabilities.
- SPPS peptide synthesis capacity
- 16000 L
Laurus Labs Investor Presentation: Key Takeaways
Q2/H1 FY27: H1 revenue ₹4,233 Cr (+31%), EBITDA ₹1,406 Cr (33.2% margin), PAT ₹809 Cr (+126%). CDMO-led growth; ₹3,000 Cr+ capex planned FY27-28.
Laurus Labs Management Change
Laurus Labs appointed Mr. Kundan Kumar Jha as Joint Company Secretary effective November 1, 2026, following Board approval. The KMP appointment advances the company's succession planning process.
Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Laurus Labs Q2 FY27 Results: Net Profit ₹436.2 Cr, Up 124.3% YoY
Laurus Labs Ltd reported revenue from operations of ₹2,206 Cr (+33.4% YoY) and net profit of ₹436.2 Cr (+124.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹436.2 Cr · +124.3% YoY
Other dividend announcements
All →Godrej Consumer Products Dividend
Godrej Consumer Products declared an interim dividend of Rs. 5 per equity share on October 29, 2026. This returns capital to shareholders alongside the half-year results.
Symphony Dividend
Symphony Limited declared a 2nd interim dividend of Rs. 2 per equity share for FY 2026-27, with record date 04-11-2026. Payment is proposed by 25-11-2026.
Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Vaibhav Global Dividend
Vaibhav Global fixed 4 November 2026 as the record date for its second interim dividend for FY 2026-27. Shareholders on that date are eligible for the payment.
Sasken Technologies Dividend
Sasken Technologies declared an interim dividend of Rs.12 per equity share for FY2026-27, alongside Q2 audited results. Record date is November 3, 2026, with payment on or before November 26, 2026.
R R Kabel Dividend
R R Kabel declared an interim dividend of Rs 6.5 per equity share for FY 2026-27 at its 28 October 2026 board meeting. The record date is 3 November 2026 and payment is expected by 13 November 2026.